- Disseminated Staphylococcus aureus infection and acute bacterial pericarditis: a case report
-
Su Hyun Bae, Song-Hyun Lee, Joon-Young Choi, Bong-Joon Kim, Soo-Jin Kim, Sung-Il Im, Hyun-Su Kim, Jung-Ho Heo
-
Kosin Med J. 2023;38(2):134-137. Published online August 16, 2022
-
DOI: https://doi.org/10.7180/kmj.22.021
-
-
Abstract
PDF PubReader ePub
- We experienced a case of disseminated Staphylococcus aureus infection with bacterial pericarditis that progressed to septic shock and multiorgan failure despite pericardiocentesis and surgical removal of the original abscess with intensive antibiotic therapy. We report this case because of the patient’s very rare and remarkable echocardiographic findings and highly turbid pericardial effusion.
- Role of biomarkers in the heart failure clinic
-
Bong-Joon Kim, Jae-Hyeong Park
-
Kosin Med J. 2022;37(1):4-17. Published online March 29, 2022
-
DOI: https://doi.org/10.7180/kmj.22.019
-
-
Abstract
PDF PubReader ePub
- Heart failure (HF) is a common cardiovascular disease that has a complex pathophysiology. Because it is the final stage of many cardiovascular diseases, proper diagnosis and treatment are crucial for prolonging patients’ survival and improving their well-being. Several biomarkers have been identified in HF, and their roles in diagnosis and prognostication have been widely investigated. Among them, natriuretic peptides are key for diagnosing HF, predicting its prognosis, and monitoring the effectiveness of HF treatment. Moreover, natriuretic peptides can also be used to treat HF. In addition to natriuretic peptides, several other biomarkers were included in the most recent HF management guidelines. Thus, we reviewed the role of the biomarkers included in these guidelines and discussed future perspectives.
|